Deutsche Bank
CGON icon

Deutsche Bank’s CG Oncology CGON Stock Holding History

Deutsche Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
197,514
+41,060
+26% +$2.68M ﹤0.01% 961
2026
Q1 		$10.6M Buy
156,454
+6,266
+4% +$355K ﹤0.01% 1034
2025
Q4 		$6.24M Buy
150,188
+77,485
+107% +$3.21M ﹤0.01% 1220
2025
Q3 		$2.93M Buy
72,703
+34,724
+91% +$1.01M ﹤0.01% 1555
2025
Q2 		$987K Buy
37,979
+2,927
+8% +$70.5K ﹤0.01% 2096
2025
Q1 		$858K Sell
35,052
-3,926
-10% -$110K ﹤0.01% 2229
2024
Q4 		$1.12M Buy
38,978
+13,589
+54% +$465K ﹤0.01% 2176
2024
Q3 		$958K Buy
25,389
+15,562
+158% +$546K ﹤0.01% 2133
2024
Q2 		$310K Sell
9,827
-866
-8% -$30K ﹤0.01% 2578
2024
Q1 		$469K Buy
+10,693
New +$437K ﹤0.01% 2387

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank's CGON Position: Q2 2026 in Review

Deutsche Bank increased its CG Oncology (CGON) stake by 26% in Q2 2026, buying an estimated $2.68M and bringing the position to 197,514 shares worth $14M. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Deutsche Bank first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Deutsche Bank held 197,514 shares of CG Oncology worth $14M as of Q2 2026.
  • Deutsche Bank bought 41,060 CG Oncology shares in Q2 2026, an estimated $2.68M.
  • CG Oncology made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #961 holding.
  • Deutsche Bank first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.